Filing Details

Accession Number:
0001140361-12-052553
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-21 19:34:01
Reporting Period:
2012-12-19
Filing Date:
2012-12-21
Accepted Time:
2012-12-21 19:34:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1116509 B C Todd 1500 Corporate Drive
Canonsburg PA 15317
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-12-19 266,749 $27.78 0 No 4 S Indirect By CSJR Partners, LP
Common Stock Disposition 2012-12-19 29,456 $28.01 37,500 No 4 S Indirect By C.B. Todd Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By CSJR Partners, LP
No 4 S Indirect By C.B. Todd Revocable Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 18,181 Direct
Common Stock 1,686 Indirect By Wife
Common Stock 168,747 Indirect By Mary Lou Todd Trusts
Footnotes
  1. This sale was executed pursuant to a 10b5-1 trading plan dated December 12, 2012.
  2. Represents the weighted price of the reporting person's disposition of 266,749 shares in transactions ranging from $27.51 to $28.35.
  3. Represents the weighted price of the reporting person's disposition of 29,546 shares in transactions ranging from $27.75 to $28.34.
  4. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1 and 2 to this Form 4.